PHARMACEUTICS
Year : 2010  |  Volume : 2  |  Issue : 1  |  Page : 27-34

Preparation and in vitro evaluation of ethylcellulose coated egg albumin microspheres of diltiazem hydrochloride


1 Department of Pharmaceutics and Pharmaceutical Technology, Shri Sarvajanik Pharmacy College, Mehsana - 384 001, Gujarat, India
2 SSR College of Pharmacy, U. T. of Dadra and Nagar, Haveli - 396 230, India
3 L. M. College of Pharmacy, Ahmedabad - 380 009, Gujarat, India

Correspondence Address:
T P Shailesh
Department of Pharmaceutics and Pharmaceutical Technology, Shri Sarvajanik Pharmacy College, Mehsana - 384 001, Gujarat
India
Login to access the Email id

Crossref citations8

DOI: 10.4103/0975-1483.62209

PMID: 21331187

Get Permissions

The aim of the present investigation was to develop sustained release ethylcellulose-coated egg albumin microspheres of diltiazem hydrochloride (DH) to improve patient compliance. The microspheres were prepared by the w/o emulsion thermal cross-linking method using different proportion of the polymer to drug ratio (1.0:1.0, 1.0:1.5 and 1.0:2.0). A 3 2 full factorial design was employed to optimize two independent variables, polymer to drug ratio (X1 ) and surfactant concentration (X2 ) on dependent variables, namely % drug loading, % drug release in 60 min (Y60 ) and the time required for 80 % drug release (t80 ) were selected as dependable variable. Optimized formulation was compared to its sustained release tablet available in market. The polymer to drug ratio was optimized to 1:1 at which a high drug entrapment efficiency 79.20% ± 0.7% and the geometric mean diameter 47.30 ± 1.5 mm were found. All batches showed a biphasic release pattern; initial burst release effect (55% DH in 1 h) and then were released completely within 6 h. In situ coating of optimized egg albumin DH microspheres using 7.5% ethylcellulose significantly reduced the burst effect and provided a slow release of DH for 8-10 h. Finally, it was concluded that ethylcellulose-coated egg albumin DH microspheres is suitable for oral SR devices in the treatment of angina pectoris, cardiac arrhythmias, and hypertension due to their size and release profile.


[FULL TEXT] [PDF]*
Print this article     Email this article
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2348    
    Printed102    
    Emailed5    
    PDF Downloaded223    
    Comments [Add]    
    Cited by others 2    

Recommend this journal